You must log in to view this page.

Precision BioSciences Inc.

NASDAQ: DTIL
Share price (8/12/25): $4.38
Market cap (8/12/25): $51.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Aquilo Capital Management, LLC

Novartis Pharma AG

Kelly John Alexander

Kelly John Alexander

News Filter

Reports Second Quarter 2025 Financial Results and Provides Business Update

Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B

Shareholder Vote Results

Reports First Quarter 2025 Financial Results and Provides Business Update

Accelerates Development of PBGENE-DMD Within Its Wholly Owned Organic Pipeline and Highlights Pre-Clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC